Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)An Exploratory Safety and Efficacy Clinical Study of CARDIX-101 for the Treatment of Chronic Bradycardia
Phase 1
Completed
- Conditions
- Bradycardia
- Interventions
- Drug: CARDIX-101A, CARDIX-101B, CARDIX-101C
- First Posted Date
- 2021-11-11
- Last Posted Date
- 2024-08-13
- Lead Sponsor
- Cardix Therapeutics LLC
- Target Recruit Count
- 20
- Registration Number
- NCT05117346
- Locations
- 🇺🇸
SpaceMed-X, San Diego, California, United States
News
No news found